News
Featured
For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed that of all previous years. The WGND is tracking 19 drug candidates that have initiated or completed a Phase 1 clinical trial for use in treating Tuberculosis. Most have been or are currently being evaluated in a Phase 2 clinical trial and one has made it to Phase 3. These 19 do...
News
27 May 2010
Press Release No:2010/432/AFR Contacts In Kampala: Steven Shalita, +256-414-302 248, sshalita@worldbank.org In Washington: Herbert Boh, +1-202-473-3548, hboh@worldbank.org The World Bank WASHINGTON, May 25, 2010 — The World Bank’s Board of Executive Directors has approved US$63.66 million to create...
26 May 2010
Professor of Medicine, University of Colorado School of Medicine, Denver, Colorado This video was recorded on November 13, 2009 at Johns Hopkins University. Michael D. Iseman Dr. Michael D. Iseman is a Professor of Medicine in the Divisions of Pulmonary Medicine and Infectious Diseases at the...
25 May 2010
Dr. Bill Bishai DURBAN, SOUTH AFRICA (May 26, 2010) – The University of KwaZulu-Natal (UKZN) and the Howard Hughes Medical Institute today announced the appointment of William R. Bishai, M.D., Ph.D., as the first permanent director of the KwaZulu-Natal Research Institute for Tuberculosis and HIV (K...
24 May 2010
www.dcwild.com/mammals.htm In part three of our talk with Dr. Michele Miller , the Chief Veterinary Officer and Director of the Center for Conservation Medicine at the Palm Beach Zoo, an expert on tuberculosis in wildlife populations, we discuss the state of funding to stop TB in wild animals. [...
23 May 2010
A Satellite Session at the 2nd TB Conference June 3, 2010; 16:00 – 18:00 MR 11, ICC, Durban Community engagement in TB drug research is growing practice, made possible by the fact that several new drug candidates are entering clinical trials. This roundtable will provide a forum for dialogue...
20 May 2010
Global Health Council On May 20, the Center hosted a briefing with leading scientists and advocates on combating the dual epidemics of HIV and TB: Changing Course: Stemming the Deadly Twin Epidemics of HIV and Tuberculosis . A complete wrap-up of the event can be found at this online press room ...
20 May 2010
Dr Klaus M Leisinger, President and Managing Director of the Novartis Foundation for Sustainable Development, and Dr Hiro Nakatani, WHO Assistant Director-General Dr Klaus M Leisinger, President and Managing Director of the Novartis Foundation for Sustainable Development , and Dr Hiro Nakatani, WHO...
19 May 2010
Professor of Microbiology and Immunology and of Molecular Genetics, Albert Einstein College of Medicine. This video was recorded on November 13, 2009 at Johns Hopkins University. Dr. Bill Jacobs Jacobs moved to Albert Einstein College of Medicine in 1985 to become a postdoc with Barry Bloom, who...
18 May 2010
Global tuberculosis drug development pipeline: the need and the reality by Zhenkun Ma, Christian Lienhardt, Helen McIlleron, Andrew J Nunn, Xiexiu Wang Today, The Lancet published a series of articles on tuberculosis, which highlights the continued devastating global impact of this disease, the...
17 May 2010
This post originally appeared on SciDev.net The patent pool may boost research into neglected diseases, such as guinea worm infection. CDC PHIL (8224) by Linda Nordling 10 May 2010 [CAPE TOWN] An industry-led ‘patent pool’, set up last year to target neglected diseases, has finally yielded some...
17 May 2010
Left unchecked, TB could claim up to 90% of lions in a national park Tuberculosis is currently a leading infectious disease in both human and animal populations across the world. Because it is an older disease, it goes under recognized in all groups – especially wildlife. While it may not generate...
12 May 2010
Grand Challenges Canada's Chief Executive Officer (CEO) Dr. Peter A. Singer looks on as Canada's Finance Minister Jim Flaherty (R) holds a microscope Dear Colleagues, It is a great pleasure to announce the launch of Grand Challenges Canada / Grands Défis Canada – an innovative organization that...
12 May 2010
Dr. Gyanu Lamichhane is Assistant Professor, Division of Infectious Diseases at the Johns Hopkins University Center for Tuberculosis Research Labs. This interview was conducted at JHU on November 13, 2009. The following bio is excerpted from this bio sketch (.pdf – 80kb) , which includes a list of...
10 May 2010
Dr. Michele Miller, Chief Veterinary Officer and Director of the Center for Conservation Medicine at the Palm Beach Zoo When we think of infectious diseases, such as HIV or Tuberculosis , we usually consider them to be a human problem – there are rarely reports of disease in animals, unless it...
9 May 2010
TBVI The University of Zaragoza (Spain), together with TuBerculosis Vaccine Initiative (TBVI) and the Spanish Fundación Ramón Areces, presents an international symposium: “Research and Development of new Tuberculosis Vaccines”. This symposium will be held on 3 and 4 June in Zaragoza, Spain. During...
